The latest trading session saw Crescent Capital BDC (CCAP - Free Report) ending at $15.81, denoting a +1.41% adjustment from its last day's close. The stock outpaced the S&P 500's daily gain of 0.73%. At the same time, the Dow added 0.62%, and the tech-heavy Nasdaq gained 0.93%.
The the stock of company has fallen by 10.56% in the past month, lagging the Finance sector's loss of 5.07% and the S&P 500's loss of 2.29%.
Investors will be eagerly watching for the performance of Crescent Capital BDC in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on November 8, 2023. The company is predicted to post an EPS of $0.56, indicating a 33.33% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $47.12 million, up 62.54% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $2.22 per share and a revenue of $180.75 million, demonstrating changes of +15.03% and +54.86%, respectively, from the preceding year.
Investors should also take note of any recent adjustments to analyst estimates for Crescent Capital BDC. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Right now, Crescent Capital BDC possesses a Zacks Rank of #3 (Hold).
Investors should also note Crescent Capital BDC's current valuation metrics, including its Forward P/E ratio of 7.01. This indicates a premium in contrast to its industry's Forward P/E of 6.84.
The Financial - SBIC & Commercial Industry industry is part of the Finance sector. This group has a Zacks Industry Rank of 85, putting it in the top 34% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow CCAP in the coming trading sessions, be sure to utilize Zacks.com.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
The latest trading session saw Crescent Capital BDC (CCAP - Free Report) ending at $15.81, denoting a +1.41% adjustment from its last day's close. The stock outpaced the S&P 500's daily gain of 0.73%. At the same time, the Dow added 0.62%, and the tech-heavy Nasdaq gained 0.93%.
The the stock of company has fallen by 10.56% in the past month, lagging the Finance sector's loss of 5.07% and the S&P 500's loss of 2.29%.
Investors will be eagerly watching for the performance of Crescent Capital BDC in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on November 8, 2023. The company is predicted to post an EPS of $0.56, indicating a 33.33% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $47.12 million, up 62.54% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $2.22 per share and a revenue of $180.75 million, demonstrating changes of +15.03% and +54.86%, respectively, from the preceding year.
Investors should also take note of any recent adjustments to analyst estimates for Crescent Capital BDC. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Right now, Crescent Capital BDC possesses a Zacks Rank of #3 (Hold).
Investors should also note Crescent Capital BDC's current valuation metrics, including its Forward P/E ratio of 7.01. This indicates a premium in contrast to its industry's Forward P/E of 6.84.
The Financial - SBIC & Commercial Industry industry is part of the Finance sector. This group has a Zacks Industry Rank of 85, putting it in the top 34% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow CCAP in the coming trading sessions, be sure to utilize Zacks.com.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
Get the latest research report on CCAP - FREE